4
Changes in Ownership
MYRIAD GENETICS INC Filed Acc 0001219036-21-000006
Chief Scientific Officer sold 40,000 shares at $31.47 ($1,258,800)
- Chief Scientific Officer acquired 40,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
LANCHBURY JERRY S · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-04-27 | Exercise or conversion : show line 1 in the form | +40,000 | $19.47 | $778,800 | 305,922 | D |
| 2021-04-27 | Sale : show line 2 in the form | −40,000 | $31.47 | $1,258,800 | 265,922 | D |
| Open-market sales · 40,000 sh · avg $31.47 · $1,258,800 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-04-27 | Exercise or conversion : show line 3 in the form Non-Qualified Stock Option (right to buy) | −40,000 | 88,000 | D |
Loading xslF345X03/edgardoc.xml…